US 10519186
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
granted A61KA61K31/7076A61K31/708
Quick answer
US patent 10519186 (Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus) held by Atea Pharmaceuticals, Inc. expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Atea Pharmaceuticals, Inc.
- Grant date
- Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 52
- CPC classes
- A61K, A61K31/7076, A61K31/708, A61K45/06, A61K9/20